News

Study identifies key elements of information clinicians need to communicate to patients with pancreatic cancer to help make informed decisions regarding preoperative therapy.

A study examining physician variation in aggressive end-of-life care among women dying of ovarian cancer suggests that interventions aimed at physician practices and decision making in end-of-life care are needed to improve the quality of...

Study findings revealed that adjuvant ipilimumab may not be a cost-effective treatment option compared to high-dose interferon in patients with resected, high-risk melanoma.

Study findings suggest that changes in the clinical management of patients with SCLC over the last 20 years have not had a significant impact on survival.

Study findings provide real-world evidence of measurable real option value of ipilimumab for patients with metastatic melanoma.

Cancer programs with high use of neoadjuvant chemotherapy achieved greater improvement in short-term mortality and equivalent gains in median overall survival compared to those with low use of neoadjuvant chemotherapy.

Study findings suggest patients with CLL taking ibrutinib are at increased risk for atrial fibrillation, bleeding, and heart failure, but not acute myocardial infarction or stroke.

Findings from a cost-effectiveness analysis support gene-specific surveillance and preventative strategies for reducing gynecologic cancer risk in women with Lynch syndrome.

Study findings suggest that belantamab mafodotin is associated with lower costs and increased quality-adjusted life years compared to selinexor plus dexamethasone for patients with relapsed/refractory MM.

Researchers developed an interactive visualization tool for kidney cancer with the potential to facilitate shared decision-making between patients and providers.